Health and Human Services News and Research

RSS

LifeVest wearable cardioverter defibrillator approved for children at risk for sudden cardiac arrest

The U.S. Food and Drug Administration today approved a new indication for the LifeVest wearable cardioverter defibrillator. The LifeVest is approved for certain children who are at risk for sudden cardiac arrest, but are not candidates for an implantable defibrillator due to certain medical conditions or lack of parental consent.

17 Dec 2015

Hospital-acquired infections prevention market in the U.S. to grow at CAGR of over 7% during 2015 - 2020

According to recently published Pharmaion report, "United States Hospital-acquired Infections Prevention Market Opportunities, 2010 - 2020", hospital-acquired infections prevention market in the United States is projected to grow at a CAGR of over 7% during 2015 - 2020.

17 Dec 2015

Drug use remains stable among teens, MTF survey shows

The 2015 Monitoring the Future survey (MTF) shows decreasing use of a number of substances, including cigarettes, alcohol, prescription opioid pain relievers, and synthetic cannabinoids ("synthetic marijuana"). Other drug use remains stable, including marijuana, with continued high rates of daily use reported among 12th graders, and ongoing declines in perception of its harms.

17 Dec 2015

Basaglar (insulin glargine injection) approved to improve glycemic control in diabetes patients

The U.S. Food and Drug Administration today approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve glycemic control in adult and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.

17 Dec 2015

TeleHealth Services forms exclusive business partnership with UbiCare

TeleHealth Services and UbiCare announce an exclusive business partnership that provides a unique, proven patient education and engagement solution for hospitals, healthcare systems, clinics and ambulatory centers.

16 Dec 2015

Children from low income environments experience higher risk of neurological impairment

Children from low income environments appear to have a higher risk of neurological impairment than those from more economically secure circumstances, according to researchers at the National Institutes of Health and other institutions. This neurological impairment appears to be distinct from the risk of cognitive and emotional delays known to accompany early-life poverty.

16 Dec 2015

Bridion injection approved to reverse effects of neuromuscular blocking drugs used during certain types of surgery

The U.S. Food and Drug Administration today approved Bridion (sugammadex) injection to reverse the effects of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide, which are used during certain types of surgery in adults.

16 Dec 2015

NWPC notifies certain patients about insider data theft

Northwest Primary Care is notifying certain patients about a security incident involving information that was stolen by a former employee. On October 13, 2015, NWPC was informed by law enforcement that the employee stole patient names, dates of birth, Social Security numbers, and credit card numbers.

13 Dec 2015

NIAID scientists successfully test prime-boost H7N9 influenza vaccine concept in clinical trial

In clinical trials, several candidate H7N9 pandemic influenza vaccines made from inactivated viruses have been shown to be safe and to generate an immune response. However, scientists believe for practical use, these potential vaccines would require multiple doses or the addition of adjuvants, which enhance the immune response.

12 Dec 2015

FDA approves Vistogard (uridine triacetate) for emergency treatment of chemotherapy overdose

The U.S. Food and Drug Administration today approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments.

12 Dec 2015

Alecensa (alectinib) approved for treatment of people with advanced ALK-positive NSCLC

The U.S. Food and Drug Administration today approved Alecensa (alectinib) to treat people with advanced (metastatic) ALK-positive non-small cell lung cancer (NSCLC) whose disease has worsened after, or who could not tolerate treatment with, another therapy called Xalkori (crizotinib).

11 Dec 2015

Halyard Health to develop high-speed machine to manufacture respirators for use during pandemic

Halyard Health Inc., formerly Kimberly-Clark Health Care, today announced that it has been awarded a contract by the Biomedical Advanced Research and Development Authority, part of the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR). Under the contract, BARDA will fund research by Halyard to develop a one-of-a-kind, high-speed machine to manufacture N95 Filtering Facepiece Respirators (FFRs) that can be used during a pandemic.

10 Dec 2015

WGU accepts applications for new master's degree program to prepare professionals in healthcare industry

Western Governors University is now accepting applications for a new online master's degree program aimed at preparing professionals for senior leadership roles in healthcare.

10 Dec 2015

TerraCom Direct receives HIPAA security compliance certification

Secured data center solutions provider TerraCom Direct has received its HIPAA security compliance certification. The operation can provide the network and infrastructure security needed to protect patient information and meet HIPAA compliance standards.

10 Dec 2015

More than half of U.S. hospitals don't require flu shots for staff, new study finds

Within weeks, flu will start spreading across North America, sickening millions of people. It will hit people with health problems and weak immune systems hardest, and may kill tens of thousands of them.

10 Dec 2015

FDA clears for marketing first cooling cap to reduce chemotherapy-induced hair loss

Today, the U.S. Food and Drug Administration cleared for marketing in the United States the first cooling cap to reduce hair loss (alopecia) in female breast cancer patients undergoing chemotherapy.

9 Dec 2015

FDA approves recombinant von Willebrand factor for treating bleeding episodes in adults with VWD

The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD.

8 Dec 2015

Kanuma approved as first treatment for patients with LAL deficiency

Today, the U.S. Food and Drug Administration approved Kanuma (sebelipase alfa) as the first treatment for patients with a rare disease known as lysosomal acid lipase (LAL) deficiency.

8 Dec 2015

FDA clears use of XSTAT 30 wound dressing to control severe bleeding in civilian population

Today, the U.S. Food and Drug Administration cleared the use of the XSTAT 30 wound dressing, an expandable, multi-sponge dressing used to control severe, life-threatening bleeding from wounds in areas that a tourniquet cannot be placed (such as the groin or armpit) in battlefield and civilian trauma settings.

8 Dec 2015

Gene therapy can restore immune systems of children and young adults with SCID-X1

Gene therapy can safely rebuild the immune systems of older children and young adults with X-linked severe combined immunodeficiency (SCID-X1), a rare inherited disorder that primarily affects males, scientists from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, have found.

7 Dec 2015

Health and Human Services News and Research

LifeVest wearable cardioverter defibrillator approved for children at risk for sudden cardiac arrest

Hospital-acquired infections prevention market in the U.S. to grow at CAGR of over 7% during 2015 - 2020

Drug use remains stable among teens, MTF survey shows

Basaglar (insulin glargine injection) approved to improve glycemic control in diabetes patients

TeleHealth Services forms exclusive business partnership with UbiCare

Children from low income environments experience higher risk of neurological impairment

Bridion injection approved to reverse effects of neuromuscular blocking drugs used during certain types of surgery

NWPC notifies certain patients about insider data theft

NIAID scientists successfully test prime-boost H7N9 influenza vaccine concept in clinical trial

FDA approves Vistogard (uridine triacetate) for emergency treatment of chemotherapy overdose

Alecensa (alectinib) approved for treatment of people with advanced ALK-positive NSCLC

Halyard Health to develop high-speed machine to manufacture respirators for use during pandemic

WGU accepts applications for new master's degree program to prepare professionals in healthcare industry

TerraCom Direct receives HIPAA security compliance certification

More than half of U.S. hospitals don't require flu shots for staff, new study finds

FDA clears for marketing first cooling cap to reduce chemotherapy-induced hair loss

FDA approves recombinant von Willebrand factor for treating bleeding episodes in adults with VWD

Kanuma approved as first treatment for patients with LAL deficiency

FDA clears use of XSTAT 30 wound dressing to control severe bleeding in civilian population

Gene therapy can restore immune systems of children and young adults with SCID-X1

Event guide: 6th Operationalize Expanded Access Programs Summit East eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News